Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1776
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $16.4M | ﹤0.01% |
341,767
+6,564
| +2% | +$507K |
|
1777
10x Genomics
TXG
$6.08B
| $16.4M | ﹤0.01% |
183,128
+158,666
| +649% | +$12.4M |
|
1778
Coca-Cola Consolidated
COKE
$12B
| $16.3M | ﹤0.01% |
712,780
+10,660
| +2% | +$250K |
|
|
SNBR
1779
DELISTED
Sleep Number
SNBR
| $16.3M | ﹤0.01% |
392,135
-14,381
| -4% | -$457K |
|
1780
Andersons Inc
ANDE
$2.54B
| $16.3M | ﹤0.01% |
1,184,744
+6,263
| +0.5% | +$90.9K |
|
1781
Agios Pharmaceuticals
AGIO
$1.89B
| $16.3M | ﹤0.01% |
304,777
-33,604
| -10% | -$1.56M |
|
1782
Mesa Laboratories
MLAB
$566M
| $16.2M | ﹤0.01% |
74,832
+287
| +0.4% | +$66.2K |
|
1783
M/I Homes
MHO
$3.8B
| $16.2M | ﹤0.01% |
468,937
+109,234
| +30% | +$2.99M |
|
1784
Bank of N.T. Butterfield & Son
NTB
$2.46B
| $16.1M | ﹤0.01% |
661,584
-5,247
| -0.8% | -$114K |
|
|
TRHC
1785
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $16.1M | ﹤0.01% |
294,752
+37,630
| +15% | +$2.15M |
|
1786
Myers Industries
MYE
$1.38B
| $16.1M | ﹤0.01% |
1,107,803
+667
| +0.1% | +$8.28K |
|
|
CSII
1787
DELISTED
Cardiovascular Systems, Inc.
CSII
| $16.1M | ﹤0.01% |
510,542
+29,093
| +6% | +$1.09M |
|
1788
Nomura Holdings
NMR
$28.5B
| $16.1M | ﹤0.01% |
3,621,842
+100,560
| +3% | +$418K |
|
1789
First Busey Corp
BUSE
$2.63B
| $16M | ﹤0.01% |
858,528
-14,187
| -2% | -$246K |
|
1790
Trupanion
TRUP
$1.08B
| $16M | ﹤0.01% |
374,825
-16,165
| -4% | -$523K |
|
1791
Supernus Pharmaceuticals
SUPN
$2.51B
| $16M | ﹤0.01% |
673,593
-15,768
| -2% | -$348K |
|
1792
Deluxe
DLX
$1.24B
| $16M | ﹤0.01% |
678,660
-4,292
| -0.6% | -$108K |
|
1793
AZZ Inc
AZZ
$4.59B
| $16M | ﹤0.01% |
465,260
+92,506
| +25% | +$2.83M |
|
|
COOP
1794
DELISTED
Mr. Cooper
COOP
| $16M | ﹤0.01% |
1,283,614
+379,919
| +42% | +$3.81M |
|
1795
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
| $15.9M | ﹤0.01% |
294,619
+65,478
| +29% | +$3.36M |
|
1796
Heron Therapeutics
HRTX
$96.8M
| $15.9M | ﹤0.01% |
1,080,537
+73,895
| +7% | +$1.21M |
|
1797
PJT Partners
PJT
$4.38B
| $15.9M | ﹤0.01% |
309,557
+27,841
| +10% | +$1.37M |
|
1798
Weis Markets
WMK
$1.94B
| $15.9M | ﹤0.01% |
316,919
+96,226
| +44% | +$4.83M |
|
1799
Regenxbio
RGNX
$659M
| $15.8M | ﹤0.01% |
429,294
+18,929
| +5% | +$706K |
|
1800
Coeur Mining
CDE
$16.7B
| $15.8M | ﹤0.01% |
3,110,532
+163,070
| +6% | +$742K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.